Down-regulation of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx)-induced CYP1A2 expression is associated with bovine lactoferrin inhibition of MeIQx-induced liver and colon carcinogenesis in rats.

Abstract

The inhibitory influence of bovine lactoferrin (bLF) on induction of preneoplastic hepatic glutathione S‐transferase placental form‐positive (GST‐P+) cell foci and colon aberrant crypt foci (ACF) by diethylnitrosamine (DEN) and 2‐amino‐3,8‐dimethylimidazo[4,5‐f]quinoxaline (MeIQx) was investigated in F344 rats. Rats were initially treated with DEN, then placed on basal diet containing MeIQx (200 ppm) alone, MeIQx plus 2% bLF, or MeIQx plus 0.2% bLF from week 2 to week 8, with partial hepatectomy performed at week 3. Concomitant administration of 2% or 0.2% bLF with MeIQx caused significant dose‐dependent decreases in both number and unit area of GST‐P+ cell foci (2% bLF, P <0.001; 0.2% bLF, P <0.01). Similar results were observed for MeIQx‐induced colon ACF in the groups without DEN treatment (2% and 0.2% bLF, P <0.05). To investigate the underlying mechanisms, we analyzed the influence of bLF on levels of cytochrome P4501A2 (CYP1A2), a metabolically activating enzyme of MeIQx in the liver. The results demonstrated that combined administration of 2% bLF significantly reduced levels of MeIQx‐induced CYP1A2 mRNA (P <0.05) and protein (P <0.05) to the normal levels, in association with reduced values for MeIQx‐DNA adducts (P <0.05), liver GST‐P+ cell foci and colon ACF. These results suggest that bLF is a chemopreventive agent for DEN alone or DEN plus MeIQx‐induced liver, and MeIQx‐induced colon carcinogenesis in rats. One possible mechanism is a normalizing down‐regulation of CYP1A2 expression by bLF, with consequent reduction of carcinogen activation and adduct formation.